To facilitate biosimilar uptake, several mechanisms aimed at reducing the acquisition cost of biosim...
Read moreTo facilitate biosimilar uptake, several mechanisms encouraging biosimilar uptake have been implemen...
Read moreMaximising the cost-saving potential of biosimilars remains a topic of much interest to payers and p...
Read moreThe law provides a legal framework for the automatic substitution of biosimilars at the level of the...
Read moreBiosimilars are becoming more widely available across Europe, with many payers at each level involve...
Read morePurpose of this study was to understand the EU member state' local market access needs in relation t...
Read moreThe government has launched a consultation that outlines the proposed changes to its price controls ...
Read morePaul Craddy is proud to be presenting at the Global Pharmaceutical Regulatory Affairs Summit in Prag...
Read moreIncluded in this issue is the implications for the UK market regarding Brexit and how the UKs CDF pe...
Read moreThe lack of a biosimilar market in the US is largely due to the substantial patent litigations which...
Read more